These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34752937)

  • 21. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma.
    Musoro JZ; Bottomley A; Coens C; Eggermont AM; King MT; Cocks K; Sprangers MA; Groenvold M; Velikova G; Flechtner HH; Brandberg Y;
    Eur J Cancer; 2018 Nov; 104():169-181. PubMed ID: 30359910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Utility of Patient-Reported Outcome Measurement Information System Domain Scales.
    Lapin B; Thompson NR; Schuster A; Katzan IL
    Circ Cardiovasc Qual Outcomes; 2019 Jan; 12(1):e004753. PubMed ID: 30587028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences.
    Fayers PM; Hays RD
    Qual Life Res; 2014 Feb; 23(1):1-4. PubMed ID: 23722635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative performance analysis of the International Classification of Functioning, Disability and Health and the Item-Perspective Classification framework for classifying the content of patient reported outcome measures.
    Rosa D; MacDermid J; Klubowicz D
    Health Qual Life Outcomes; 2021 Apr; 19(1):132. PubMed ID: 33892735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.
    Musoro JZ; Coens C; Singer S; Tribius S; Oosting SF; Groenvold M; Simon C; Machiels JP; Grégoire V; Velikova G; Cocks K; Sprangers MAG; King MT; Bottomley A;
    Head Neck; 2020 Nov; 42(11):3141-3152. PubMed ID: 32627261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinically significant differences in patient-reported outcomes evaluations in chronic spontaneous urticaria.
    Baiardini I; Canonica GW; La Grutta S; Braido F
    Curr Opin Allergy Clin Immunol; 2020 Jun; 20(3):261-267. PubMed ID: 32073436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating minimal important differences for several scales assessing function and quality of life in patients with attention-deficit/hyperactivity disorder.
    Hodgkins P; Lloyd A; Erder MH; Setyawan J; Weiss MD; Sasané R; Nafees B
    CNS Spectr; 2017 Feb; 22(1):31-40. PubMed ID: 27535815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches.
    Yost KJ; Cella D; Chawla A; Holmgren E; Eton DT; Ayanian JZ; West DW
    J Clin Epidemiol; 2005 Dec; 58(12):1241-51. PubMed ID: 16291468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of Life in the Tube Versus Trabeculectomy Study.
    Kotecha A; Feuer WJ; Barton K; Gedde SJ;
    Am J Ophthalmol; 2017 Apr; 176():228-235. PubMed ID: 28161049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology-A Scoping Review.
    Speeckaert R; Belpaire A; Herbelet S; Speeckaert MM; van Geel N
    J Pers Med; 2022 Jul; 12(7):. PubMed ID: 35887664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE.
    Beynon R; Leeflang MM; McDonald S; Eisinga A; Mitchell RL; Whiting P; Glanville JM
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):MR000022. PubMed ID: 24022476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying the minimal important difference in patient-reported outcome measures in the field of people with severe mental illness: a pre-post-analysis of the Illness Management and Recovery Programme.
    Beentjes TAA; Teerenstra S; Vermeulen H; Goossens PJJ; der Sanden MWGN; van Gaal BGI
    Qual Life Res; 2021 Jun; 30(6):1723-1733. PubMed ID: 33594528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the Minimal Important Difference for the Western Ontario Rotator Cuff Index (WORC) in adults with shoulder pain associated with partial-thickness rotator cuff tears.
    Braun C; Handoll HH
    Musculoskelet Sci Pract; 2018 Jun; 35():30-33. PubMed ID: 29471221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy.
    Musoro JZ; Sodergren SC; Coens C; Pochesci A; Terada M; King MT; Sprangers MAG; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
    Colorectal Dis; 2020 Dec; 22(12):2278-2287. PubMed ID: 32767619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument.
    Yost KJ; Sorensen MV; Hahn EA; Glendenning GA; Gnanasakthy A; Cella D
    Value Health; 2005; 8(2):117-27. PubMed ID: 15804320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issues.
    Wang Y; Ghadimi M; Wang Q; Hou L; Zeraatkar D; Iqbal A; Ho C; Yao L; Hu M; Ye Z; Couban R; Armijo-Olivo S; Bassler D; Briel M; Gluud LL; Glasziou P; Jackson R; Keitz SA; Letelier LM; Ravaud P; Schulz KF; Siemieniuk RAC; Brignardello-Petersen R; Guyatt GH
    J Clin Epidemiol; 2022 Dec; 152():218-225. PubMed ID: 36424692
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.